Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage

Microbes and Infection

Volumn 11, Issue 2, 2009, Pages 264-273

  Medeiros, Gabriela A ^a   Silvério, Jaline C ^a   Marino, Ana Paula M P ^a   Roffê, Ester ^b   Vieira, Valeska ^a   Kroll Palhares, Karina ^a   Carvalho, Cristiano E ^a   Silva, Andréa Alice ^a,c   Teixeira, Mauro M ^b   Lannes Vieira, Joseli ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chagas disease; heart disease; Met RANTES; myocarditis; Trypanosoma cruzi

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CONNEXIN 43; CREATINE KINASE MB; FIBRONECTIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; N TERMINAL METHIONYLATED RANTES; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C3H MOUSE; CARDITIS; CELL COMPARTMENTALIZATION; CELL COUNT; CELL MIGRATION; CHAGAS DISEASE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HEART DISEASE; HEART INJURY; LYMPHOCYTE ACTIVATION; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; T LYMPHOCYTE; TISSUE LEVEL; TRYPANOSOMA CRUZI;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CHEMOKINE CCL5; CONNEXIN 43; FEMALE; HEART; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; INTERLEUKIN-13; MICE; MICE, INBRED C3H; MYOCARDIUM; RECEPTORS, CCR1; RECEPTORS, CCR5; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

MUS; TRYPANOSOMA CRUZI;

EID: 61449103434     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.11.012     Document Type: Article

References (33)

1. Coura J.R. Chagas disease: what is known and what is needed - a background article. Mem. Inst. Oswaldo Cruz. 102 (2007) 113-122
2. Freitas H.F., Chizzola P.R., Paes A.T., Lima A.C., and Mansur A.J. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int. J. Cardiol 102 (2005) 239-247
3. Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease?. Trends Parasitol. 21 (2005) 513-516
4. Marino A.P., Silva A., dos Santos P., Pinto L.M., Gazzinelli R.T., Teixeira M.M., and Lannes-Vieira J. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 110 (2004) 1443-1449
5. Teixeira M.M., Gazzinelli R.T., and Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Immunol. 18 (2002) 262-265
6. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2 (2002) 106-115
7. Aliberti J.C., Machado F.S., Souto J.T., Campanelli A.P., Teixeira M.M., Gazzinelli R.T., and Silva J.S. Beta-chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect. Immun. 67 (1999) 4819-4826
8. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., and Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102 (2000) 3003-3008
9. Filippatos G., Parissis J.T., Adamopoulos S., and Kardaras F. Chemokines in cardiovascular remodeling: clinical and therapeutic implications. Curr. Mol. Med. 3 (2003) 139-147
10. Talvani A., Rocha M.O., Barcelos L.S., Gomes Y.M., Ribeiro A.L., and Teixeira M.M. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin. Infect. Dis. 38 (2004) 943-950
11. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Busek S.C., Teixeira M.M., Silva J.S., and Correa-Oliveira R. Type 1 chemokine receptor expression in Chagas disease correlates with morbidity in cardiac patients. Infect. Immun. 73 (2005) 7960-7966
12. Talvani A., Rocha M.O., Ribeiro A.L., Correa-Oliveira R., and Teixeira M.M. Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas Disease. J. Infect. Dis. 189 (2004) 214-220
13. Silva A.A., Roffê E., Santiago H., Marino A.P., Kroll-Palhares K., Teixeira M.M., Gazzinelli R.T., and Lannes-Vieira J. Trypanosoma cruzi-triggered meningoencephalitis is a CCR1/CCR5-independent inflammatory process. J. Neuroimmunol. 184 (2007) 156-163
14. Calzada J.E., Nieto A., Beraun Y., and Martin J. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 58 (2001) 154-158
15. High activation phenotype and expression of IFN-γ-inducible adhesion and chemoattractant molecules. Microbes Infect. 3 (2001) 971-984
16. Michailowsky V., Celes M.R., Marino A.P., Silva A.A., Vieira L.Q., Rossi M.A., Gazzinelli R.T., Lannes-Vieira J., and Silva J.S. Intercellular adhesion molecule 1 deficiency leads to impaired recruitment of T lymphocytes and enhanced host susceptibility to infection with Trypanosoma cruzi. J. Immunol. 173 (2004) 463-470
17. de Souza A.P., Olivieri B.P., de Castro S.L., and Araújo-Jorge T.C. Enzymatic markers of heart lesion in mice infected with Trypanosoma cruzi and submitted to benznidazole chemotherapy. Parasitol. Res. 86 (2000) 800-808
18. Machado F.S., Koyama N.S., Carregaro V., Ferreira B.R., Milanezi C.M., Teixeira M.M., Rossi M.A., and Silva J.S. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J. Infect. Dis. 191 (2005) 627-636
19. Hardison J.L., Wrightsman R.A., Carpenter P.M., Kuziel W.A., Lane T.E., and Manning J.E. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect. Immun. 74 (2006) 135-143
20. + T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade. Mem. Inst. Oswaldo Cruz. 103 (2008) 375-385
21. de Meis J., Mendes-da-Cruz D.A., Farias-de-Oliveira D.A., Correa-de-Santana E., Pinto-Mariz F., Cotta-de-Almeida V., Bonomo A., and Savino W. Atrophy of mesenteric lymph nodes in experimental Chagas' disease: differential role of Fas/Fas-L and TNFRI/TNF pathways. Microbes Infect. 8 (2006) 221-231
22. Marino A.P.M.P., Silva A.A., Pinho R.T., and Lannes-Vieira J. Trypanosoma cruzi infection: a continuous invader-host cell cross talk with participation of extracellular matrix, and adhesion and chemoattractant molecules. Braz. J. Med. Biol. Res. 36 (2003) 1121-1133
23. Severs N.J., Dupont E., Thomas N., Kaba R., Rothery S., Jain R., Sharpey K., and Fry C.H. Alterations in cardiac connexin expression in cardiomyopathies. Adv. Cardiol. 42 (2006) 228-242
24. de Carvalho A.C., Tanowitz H.B., Wittner M., Dermietzel R., Roy C., Hertzberg E.L., and Spray D.C. Gap junction distribution is altered between cardiac myocytes infected with Trypanosoma cruzi. Circ. Res. 70 (1992) 733-742
25. + lymphocytes. Am. J. Trop. Med. Hyg. 48 (1993) 637-644
26. Abel L.C., Rizzo L.V., Ianni B., Albuquerque F., Bacal F., Carrara D., Bocchi E.A., Teixeira H.C., Mady C., Kalil J., and Cunha-Neto E. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun. 17 (2001) 99-107
27. Marino A.P.M.P., Azevedo M.I.P., and Lannes-Vieira J. Differential expression of adhesion molecules shaping the T-cell subset prevalence during the early phase of autoimmune and Trypanosoma cruzi-elicited myocarditis. Mem. Inst. Oswaldo Cruz. 98 (2003) 945-952
28. Weber K.S., Klickstein L.B., and Weber C. Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains. Mol. Biol. Cell. 10 (1999) 861-873
29. Murphy A., Long A., Volkov Y., and Kelleher D. Cross-linking of LFA-1 induces secretion of macrophage inflammatory protein (MIP)-l alpha and MIP-1beta with consequent directed migration of activated lymphocytes. Eur. J. Immunol. 30 (2000) 3006-3011
30. Cummings K.L., and Tarleton R.L. Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect. Immun. 72 (2004) 4081-4089
31. Silva J.S., Machado F.S., and Martins G.A. The role of nitric oxide in the pathogenesis of Chagas disease. Front. Biosci. 8 (2003) s314-s325
32. Perez-Fuentes R., Guegan J.F., Barnabe C., Lopez-Colombo A., Salgado-Rosas H., Torres-Rasgado E., Briones B., Romero-Diaz M., Ramos-Jimenez J., and Sanchez-Guillen M.d.C. Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int. J. Parasitol. 33 (2003) 293-299
33. Tzelepis F., Persechini P.M., and Rodrigues M.M. Modulation of CD4+ T cell-dependent specific cytotoxic CD8+ T cells differentiation and proliferation by the timing of increase in the pathogen load. PLoS ONE 2 (2007) e393